NHS Long-Term Plan: Implementation

Debate between Matt Hancock and Luke Graham

Monday 1st July 2019 Commons Chamber

[Matt Hancock]

Yes, I shall be happy to ensure that that meeting happens. As for Island healthcare costs, my hon. Friend is right to say that the Isle of Wight is unique in its health geography, and that there are places in this country—almost certainly including the Isle of Wight—where healthcare costs are higher because of the geography. There is a programme for smaller hospitals that are necessarily smaller because of the local geography, as they need special attention.

As I have said, I shall be happy to ensure that the meeting goes ahead, and I shall continue to talk to my hon. Friend, who makes the case for the Isle of Wight better than any other.

[Luke Graham (Ochil and South Perthshire) (Con)]

Tomorrow I shall attend the funeral of my Auntie Bib, who has just died of cancer. It was discovered at quite a late stage. May I press my right hon. Friend to ensure that rapid access diagnosis centres are rolled out as quickly as humanly possible, and to give the House more details? May I also—as is my job—remind him that he is, of course, the Secretary of State for Health and Social Care for this entire United Kingdom, and ask him how he intends to engage with devolved authorities when targets are being missed to ensure that standards are maintained across the island? Our constituents are all British citizens, and they all require and deserve the same level of support.

[Matt Hancock]

I am sure that the whole House will want to pass our condolences to my hon. Friend, to his family, and to friends of his aunt. In a way, it is fitting to end this session with a very personal example of why early diagnosis matters.

As for my hon. Friend’s second point, ensuring that we have high-quality health services throughout the UK is, of course, vital. It is true that there has been a smaller increase in funding for the NHS in Scotland, and a consequent smaller increase in the number of healthcare professionals there. We need an improvement right across this country. We are delivering that in England, and I am sure that my hon. Friend will continue to make the case for better health services in Scotland from the Scottish National party Government, who receive the money from the UK Treasury but do not put all of it towards the NHS.

Access to Medical Cannabis

Debate between Matt Hancock and Luke Graham

Monday 8th April 2019 Commons Chamber

[Matt Hancock]

One of the great frustrations for me, for the Home Secretary and, of course, for the families is that, before the law was changed on 1 November, that course of action was open. For a few dozen cases, the Home Secretary made those special licences to allow for the use of medicinal cannabis. He and I changed the law together to try to make sure that medicinal cannabis is available on a mainstream basis. Now it is available on a mainstream basis, as a normal drug, it therefore needs clinical sign-off. The problem is there are so many cases where that clinical sign-off has not been forthcoming. That is a source of immense frustration to me, as I hope the hon. Lady can imagine, and it is what we are trying to resolve.

[Luke Graham (Ochil and South Perthshire) (Con)]

Does my right hon. Friend agree that we should be led by evidence? As our scientific knowledge continues to progress, so should the views and the laws made in this House. Will he provide more clarity, not just in this instance but as new and more radical drugs become available in the near future, on how our constituents and this House could benefit and push through laws more quickly?

[Matt Hancock]

My hon. Friend makes a very important point. To ensure that the use of medical cannabis becomes mainstream, we need to ensure that the evidence base is there. Essentially, doctors think there is a much deeper evidence base for CBD than for THC. There is a broader point, which is that the medical profession and this House need to keep up to speed with the evidence as it is developed. In this case, that means going out of our way to develop the evidence and to have clinical trials in which some of the patients who want the drug can participate. That will provide the evidence base that allows the vast array of specialists to prescribe it.

Oral Answers to Questions

Debate between Matt Hancock and Luke Graham

Thursday 22nd March 2018 Commons Chamber

[Matt Hancock]

I welcome the generosity of that group and of many others, but the hon. Gentleman is right—it is not all down to local generosity, welcome as that must be. We have invested over £400 million in music provision through music education hubs, and we continue to invest at the rate of £75 million a year.

[Luke Graham (Ochil and South Perthshire) (Con)]

Owing to stinging cuts from Edinburgh, local authorities in my constituency have had to face cuts to music education. Is there anything that my right hon. Friend can do to provide support from Westminster to local authorities in Scotland, to protect the services that the SNP will not?

[Matt Hancock]

As my hon. Friend knows, we have protected per pupil funding in England, but of course education is devolved in Scotland. I do not know whether the Scottish Government have provided anything like the support that we have for music education hubs here in England. The money that we have put into music education hubs goes an awfully long way, and frankly it looks like the SNP Government need to do more.